BIOLQ (Biolase) Cyclically Adjusted FCF per Share: $-2,113.08 (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOLQ Biolase Inc BIOLQ
16 GF Score
Price $0.00
View Full Analysis

What is Biolase Cyclically Adjusted FCF per Share?

Biolase BIOLQ -99.00% 16 Cyclically Adjusted FCF per Share is $-2,113.08 as of Sep. 2024. GuruFocus rates BIOLQ with a GF Score™ of 16/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biolase's adjusted free cash flow per share for the three months ended in Sep. 2024 was $-0.124. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2,113.08 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-26), Biolase's current stock price is $0.0001. Biolase's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was $-2,113.08. Biolase's Cyclically Adjusted Price-to-FCF of today is .


Biolase  (OTCPK:BIOLQ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biolase Cyclically Adjusted FCF per Share Related Terms


Biolase Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Biolase's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolase Cyclically Adjusted FCF per Share Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,203.86 -3,083.41 -2,658.39 -2,767.99 -2,426.33

Biolase Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,540.74 -2,426.33 -2,343.52 -2,351.12 -2,113.08

BIOLQ vs OPGN, AFIB, ABT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Biolase's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolase Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biolase's Cyclically Adjusted Price-to-FCF falls into.


BIOLQ
16GF Score
Biolase Inc BIOLQ
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biolase Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biolase's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.124/315.3010*315.3010
=-0.124

Current CPI (Sep. 2024) = 315.3010.

Biolase Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -1,482.750 234.812 -1,991.008
201503 -1,526.000 236.119 -2,037.741
201506 -768.400 238.638 -1,015.250
201509 -947.000 237.945 -1,254.870
201512 -842.000 236.525 -1,122.433
201603 -1,023.000 238.132 -1,354.513
201606 -332.400 241.018 -434.847
201609 -346.200 241.428 -452.132
201612 -875.500 241.432 -1,143.370
201703 -1,066.000 243.801 -1,378.628
201706 -1,242.800 244.955 -1,599.706
201709 -572.833 246.819 -731.770
201712 -596.857 246.524 -763.372
201803 -608.000 249.554 -768.182
201806 -448.875 251.989 -561.654
201809 -280.625 252.439 -350.506
201812 -500.625 251.233 -628.292
201903 -630.250 254.202 -781.734
201906 -190.000 256.143 -233.882
201909 -162.222 256.759 -199.209
201912 -431.000 256.974 -528.827
202003 -318.692 258.115 -389.299
202006 -351.800 257.797 -430.272
202009 -63.788 260.280 -77.272
202012 -35.026 260.474 -42.399
202103 -120.500 264.877 -143.439
202106 -63.533 271.696 -73.730
202109 -60.377 274.310 -69.399
202112 -55.984 278.802 -63.313
202203 -134.274 287.504 -147.256
202206 -112.885 296.311 -120.120
202209 -121.368 296.808 -128.930
202212 -77.603 296.797 -82.441
202303 -19.040 301.836 -19.889
202306 -7.191 305.109 -7.431
202309 -2.349 307.789 -2.406
202312 -0.722 306.746 -0.742
202403 -0.333 312.332 -0.336
202406 -0.022 314.175 -0.022
202409 -0.124 315.301 -0.124

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2,113.08 mean?
Biolase (BIOLQ) has a Cyclically Adjusted FCF per Share of $-2,113.08 as of Sep. 2024. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biolase and its competitors.
Is Biolase's Cyclically Adjusted FCF per Share too high?
Biolase's current Cyclically Adjusted FCF per Share is $-2,113.08. Overall, Biolase has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Biolase's Cyclically Adjusted FCF per Share compare to OPGN and AFIB?
Biolase's Cyclically Adjusted FCF per Share of $-2,113.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biolase and its competitors. Biolase's current Cyclically Adjusted FCF per Share is $-2,113.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biolase stock overvalued right now?
Biolase (BIOLQ) has a current Cyclically Adjusted FCF per Share of $-2,113.08. The current Cyclically Adjusted FCF per Share is $-2,113.08. Biolase's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Biolase (BIOLQ), the current Cyclically Adjusted FCF per Share is $-2,113.08 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biolase Business Description

Address 27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
16GF Score

Get the complete analysis for BIOLQ

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price